Inter-rater reliability study of the Japanese version of the diagnostic clinical interview for drug withdrawal post SSRIs or SNRIs (DID-W1-J).
作者信息
Nakamura Tomoyuki, Oe Misari, Uematsu Ken, Hori Hikaru, Ozone Motohiro, Cosci Fiammetta
机构信息
Department of Neuropsychiatry Kurume University School of Medicine Kurume Fukuoka Japan.
Uematsu Mental Clinic Chikugo Fukuoka Japan.
出版信息
PCN Rep. 2025 Jan 8;4(1):e70050. doi: 10.1002/pcn5.70050. eCollection 2025 Mar.
Abstract
摘要
相似文献
1
Inter-rater reliability study of the Japanese version of the diagnostic clinical interview for drug withdrawal post SSRIs or SNRIs (DID-W1-J).选择性5-羟色胺再摄取抑制剂或5-羟色胺-去甲肾上腺素再摄取抑制剂停药后药物戒断诊断临床访谈日语版（DID-W1-J）的评分者间信度研究
PCN Rep. 2025 Jan 8;4(1):e70050. doi: 10.1002/pcn5.70050. eCollection 2025 Mar.
2
The Diagnostic clinical Interview for Drug Withdrawal 1 (DID-W1) – New Symptoms of Selective Serotonin Reuptake Inhibitors (SSRI) or Serotonin Norepinephrine Reuptake Inhibitors (SNRI): inter-rater reliability.药物戒断诊断临床访谈1（DID-W1）——选择性5-羟色胺再摄取抑制剂（SSRI）或5-羟色胺去甲肾上腺素再摄取抑制剂（SNRI）的新症状：评分者间信度
Riv Psichiatr. 2018 Mar-Apr;53(2):95-99. doi: 10.1708/2891.29158.
3
Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors.评估选择性 5-羟色胺再摄取抑制剂或 5-羟色胺去甲肾上腺素再摄取抑制剂剂量减少或停药后戒断综合征的半结构式访谈和量表的临床实用性。
J Clin Psychopharmacol. 2022;42(1):17-22. doi: 10.1097/JCP.0000000000001491.
4
Selective Serotonin Reuptake Inhibitor and Serotonin-Noradrenaline Reuptake Inhibitor Withdrawal Changes DSM Presentation of Mental Disorders: Results from the Diagnostic Clinical Interview for Drug Withdrawal.选择性 5-羟色胺再摄取抑制剂和 5-羟色胺-去甲肾上腺素再摄取抑制剂戒断改变 DSM 精神障碍表现：来自药物戒断诊断临床访谈的结果。
Psychother Psychosom. 2024;93(5):340-345. doi: 10.1159/000540031. Epub 2024 Jul 23.
5
Feasibility and Inter-rater Reliability of the Japanese Version of the Intensive Care Unit Mobility Scale.《重症监护病房活动量表日语版的可行性及评分者间信度》
Cureus. 2024 Apr 27;16(4):e59135. doi: 10.7759/cureus.59135. eCollection 2024 Apr.
6
Verifying the Japanese Version of Pediatric Delirium and Withdrawal Syndrome Assessment Scale: SOS-PD Validation Study for Iatrogenic Withdrawal Syndrome.验证小儿谵妄与戒断综合征评估量表的日文版：医源性戒断综合征的SOS-PD验证研究
Children (Basel). 2025 Mar 17;12(3):372. doi: 10.3390/children12030372.
7
The inter-rater reliability of the Japanese version of the Inventory of Depressive Symptomatology, clinician version.《抑郁症状量表（临床版）》日文版的评定者间信度。
Hum Psychopharmacol. 2011 Apr;26(3):267-9. doi: 10.1002/hup.1201.
8
Reliability, validity, and minimal clinically important differences of the Japanese version of the early clinical assessment of balance in children with cerebral palsy.日本版脑性瘫痪儿童早期平衡临床评估的可靠性、有效性和最小临床重要差异。
Disabil Rehabil. 2022 Nov;44(23):7283-7289. doi: 10.1080/09638288.2021.1977859. Epub 2021 Sep 19.
9
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.用于预防成人紧张型头痛的选择性5-羟色胺再摄取抑制剂（SSRIs）和5-羟色胺-去甲肾上腺素再摄取抑制剂（SNRIs）
Cochrane Database Syst Rev. 2015 May 1;2015(5):CD011681. doi: 10.1002/14651858.CD011681.
10
Reliability and consistency of the Japanese version of the Primary Lateral Sclerosis Functional Rating Scale.原发性侧索硬化功能评定量表日语版的信度和一致性。
BMC Neurol. 2024 Aug 13;24(1):282. doi: 10.1186/s12883-024-03729-6.
本文引用的文献
1
Selective Serotonin Reuptake Inhibitor and Serotonin-Noradrenaline Reuptake Inhibitor Withdrawal Changes DSM Presentation of Mental Disorders: Results from the Diagnostic Clinical Interview for Drug Withdrawal.选择性 5-羟色胺再摄取抑制剂和 5-羟色胺-去甲肾上腺素再摄取抑制剂戒断改变 DSM 精神障碍表现：来自药物戒断诊断临床访谈的结果。
Psychother Psychosom. 2024;93(5):340-345. doi: 10.1159/000540031. Epub 2024 Jul 23.
2
Safety profile of antidepressant for Japanese adults with major depressive disorder: A systematic review and network meta-analysis.日本成年重度抑郁症患者抗抑郁药的安全性概况：一项系统评价和网状荟萃分析。
Psychiatry Clin Neurosci. 2024 Feb;78(2):142-144. doi: 10.1111/pcn.13622. Epub 2023 Dec 10.
3
Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors.评估选择性 5-羟色胺再摄取抑制剂或 5-羟色胺去甲肾上腺素再摄取抑制剂剂量减少或停药后戒断综合征的半结构式访谈和量表的临床实用性。
J Clin Psychopharmacol. 2022;42(1):17-22. doi: 10.1097/JCP.0000000000001491.
4
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications.精神药物停药后出现的急性和持续戒断综合征。
Psychother Psychosom. 2020;89(5):283-306. doi: 10.1159/000506868. Epub 2020 Apr 7.
5
Understanding and Managing Withdrawal Syndromes After Discontinuation of Antidepressant Drugs.理解和管理抗抑郁药停药后戒断综合征。
J Clin Psychiatry. 2019 Nov 26;80(6):19com12794. doi: 10.4088/JCP.19com12794.
6
Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review.SSRIs 停药后出现的戒断症状：系统评价。
Psychother Psychosom. 2018;87(4):195-203. doi: 10.1159/000491524. Epub 2018 Jul 17.
7
The Diagnostic clinical Interview for Drug Withdrawal 1 (DID-W1) – New Symptoms of Selective Serotonin Reuptake Inhibitors (SSRI) or Serotonin Norepinephrine Reuptake Inhibitors (SNRI): inter-rater reliability.药物戒断诊断临床访谈1（DID-W1）——选择性5-羟色胺再摄取抑制剂（SSRI）或5-羟色胺去甲肾上腺素再摄取抑制剂（SNRI）的新症状：评分者间信度
Riv Psichiatr. 2018 Mar-Apr;53(2):95-99. doi: 10.1708/2891.29158.
8
New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal.选择性5-羟色胺再摄取抑制剂撤药的新分类
Psychother Psychosom. 2015;84(2):63-71. doi: 10.1159/000371865. Epub 2015 Feb 21.
9
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.《迷你国际神经精神病学访谈量表（M.I.N.I.）》：一种针对《精神疾病诊断与统计手册》第四版（DSM-IV）和《国际疾病分类》第十版（ICD-10）的结构化诊断性精神科访谈量表的开发与验证
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57.
10
Antidepressant discontinuation: a review of the literature.抗抑郁药停药：文献综述
J Clin Psychiatry. 1997;58 Suppl 7:11-5; discussion 16.
Zotero 插件